CLOV · Clover Health Investments, Corp
$4.82
+2.33% last session
End-of-day data · close of 2026-09-11
Market cap
$3B
Enterprise value
$2B
Trailing P/E
—
Forward P/E
31.4
Dividend yield
—
Beta
2.48
Avg volume
5M
Employees
1K
Daily Change %
2.33%
5 Days Change
2.00%
10 Days Change
4.58%
30 Days Change
-1.14%
60 Days Change
-2.25%
Month to Day Change
0.93%
Year to Day Change
84.68%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — CLOV
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-06
Latest call per bank · past 12 months
UBS
Neutral$5.00
+6.2% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-06 | UBS | Maintains | Neutral | $4.75 → $5.00 |
| 2026-07-21 | Canaccord Genuity | Maintains | Buy | $4.20 → $5.50 |
| 2026-06-11 | UBS | Maintains | Neutral | $2.75 → $4.75 |
| 2026-06-04 | Canaccord Genuity | Maintains | Buy | $3.20 → $4.20 |
| 2026-03-20 | Canaccord Genuity | Maintains | Buy | $3.70 → $3.20 |
| 2026-03-05 | Leerink Partners | Maintains | Market Perform | $3.00 → $2.50 |
| 2026-01-20 | Canaccord Genuity | Maintains | Buy | $3.70 |
| 2025-11-06 | Canaccord Genuity | Maintains | Buy | $4.10 → $3.70 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 66 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 8.3% above the 50-day MA ($4.45).
- Price vs 200-day MA: Trading 51.6% above the 200-day MA ($3.18).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is positive (+0.07) — short-term momentum is improving.
- 52-week range: Price sits between the 52-week low ($1.70) and high ($5.41).
CLOV Price Chart
Loading chart for CLOV…
Fundamentals
About Clover Health Investments, Corp
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
More in Healthcare Plans
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.